DifGen Wins FDA IND Clearance for Breast Cancer Therapy
Miramar, Fla., July 27, 2026 DifGen Pharmaceuticals LLC has announced that the U.S. Food and Drug Administration (FDA) has...
biopharma innovation
Advertisement
Insilico Medicine Presents ISM6331 Phase 1 Data at ESMO
Cambridge, MA, July 27, 2026 Insilico Medicine has announced that first-in-human Phase 1 clinical trial data for ISM6331, its...
Levee Medical Completes ARID II Trial Enrollment for Voro
DURHAM, N.C., July 14, 2026 Levee Medical has reached a significant clinical development milestone with the successful completion of...
Chai Discovery Secures $400M to Transform AI Drug Discovery
SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...
Simulations Plus to Join Altaris in $375M Acquisition Deal
RESEARCH TRIANGLE PARK, N.C., June 16, 2026 Simulations Plus, a global leader in model-informed and AI-accelerated drug development software,...
Advertisements
BMS and Hengrui Form $15 Billion Drug Development Alliance
SHANGHAI, China and PRINCETON, N.J., May 12, 2026 Hengrui Pharma and Bristol Myers Squibb (BMS) have announced a landmark...
LEO Pharma Acquires Replay to Boost Gene Therapy
Ballerup, Denmark | April 30, 2026 LEO Pharma has announced a definitive agreement to acquire Replay, significantly expanding its...
Precision BioSciences Expands ELIMINATE-B Trial in EU
Durham, North Carolina, U.S. | April 15, 2026 Precision BioSciences has announced a significant clinical and regulatory milestone with...
Akebia Therapeutics Doses First in AKB-9090 Trial
CAMBRIDGE, Mass., April 13, 2026 Akebia Therapeutics, Inc., a biopharmaceutical company focused on kidney disease, has announced that the...
Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026
CAMBRIDGE, Mass., April 9, 2026 Vedanta Biosciences, a late clinical-stage biopharmaceutical company, has announced new scientific presentations showcasing its...
Advertisement
